ARVN
NASDAQ · Pharmaceuticals
Arvinas Inc
$8.75
+0.07 (+0.81%)
Open$8.81
Previous Close$8.68
Day High$8.98
Day Low$8.64
52W High$14.51
52W Low$6.06
Volume—
Avg Volume1.13M
Market Cap572.13M
P/E Ratio61.52
EPS$0.16
SectorPharmaceuticals
Analyst Ratings
Buy
24 analysts
Price Target
+656.8% upside
Current
$8.75
$8.75
Target
$66.22
$66.22
$44.47
$66.22 avg
$75.30
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 242.18M | 192.27M | 233.97M |
| Net Income | -74,514,107 | -53,241,264 | 39.13M |
| Profit Margin | -30.8% | -29.2% | 16.7% |
| EBITDA | -106,520,649 | -80,338,692 | 67.61M |
| Free Cash Flow | — | — | 28.90M |
| Rev Growth | +26.0% | +26.0% | +1.6% |
| Debt/Equity | 0.00 | 0.00 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |